Boundless Bio
Series C
Precision oncology therapeutic
Boundless Bio is a precision oncology company that develops therapeutics directed against extrachromosomal DNA in aggressive cancers.
Founders
P
LinkedIn ↗
Similar Startups
Ceribell
Series C
Point-of-care EEG for seizure triage and treatment optimization
Freenome
Blood test to detect colorectal cancer
Mira
Hormone monitor and supplements
Janux Therapeutics
Immunotherapy to fight tumors
Epikast
Series B
Engage patients and health providers
ModMed
Software for specialty medical practices